Position in ICLR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,910
-$35,012 QoQ
Shares Held
11
-94.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#398
of 422 holders
Holding Since
Dec 2022
11 quarters on record
Common Shares in ICLR Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Park Place Capital Corp holds $1,838,593 across 12 Diagnostics & Research names. ICLR ranks #12 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,689 | $1,348,155 | |
| 2 | DHR |
Danaher Corp /De/
|
725 | $138,098 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
208 | $110,154 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
88 | $46,326 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
185 | $41,956 | |
| 6 | LH |
Labcorp Holdings Inc.
|
143 | $40,040 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
207 | $39,996 | |
| 8 | A |
Agilent Technologies, Inc.
|
233 | $30,949 |
All Filings in ICLR
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,910 | 11 | Shares | Sole | 2026-08-14 | |
| 2025-03-31 | $36,922 | 211 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $47,184 | 225 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $16,951 | 59 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $18,494 | 59 | Shares | Sole | 2024-07-02 | |
| 2024-03-31 | $21,500 | 64 | Shares | Sole | 2024-04-18 | |
| 2023-12-31 | $18,116 | 64 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $96,776 | 393 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $98,328 | 393 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $78,601 | 368 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $69,153 | 356 | Shares | Sole | 2023-02-14 | |
| No filing history on record for this holder in this stock. | ||||||